Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy-Reference-Cited by-同舟云学术

Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy

Published:2023-04-29 Issue:5-6 Volume:23 Page:185-197
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Galis Peter,Bartosova Linda,Farkasova Veronika,Szobi Adrian,Horvath Csaba,Kovacova Dominika,Adameova Adriana,Rajtik Tomas

Funder

Farmaceutická fakulta, Univerzita Komenského v Bratislave

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Agentúra na Podporu Výskumu a Vývoja

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s12012-023-09793-7.pdf

Reference66 articles.

1. Chung, W. B., & Youn, H. J. (2016). Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity. The Korean Journal of Internal Medicine, 31(4), 625–633. https://doi.org/10.3904/kjim.2016.017

2. Volkova, M., & Russell, R., 3rd. (2011). Anthracycline cardiotoxicity: Prevalence, pathogenesis and treatment. Current Cardiology Reviews, 7(4), 214–220. https://doi.org/10.2174/157340311799960645

3. Rivera, E. (2003). Liposomal anthracyclines in metastatic breast cancer: Clinical update. The oncologist, 8(Suppl 2), 3–9. https://doi.org/10.1634/theoncologist.8-suppl_2-3

4. Martins-Teixeira, M. B., & Carvalho, I. (2020). Antitumour anthracyclines: progress and perspectives. ChemMedChem, 15(11), 933–948. https://doi.org/10.1002/cmdc.202000131

5. Shevchuk, O. O., Posokhova, E. A., Sakhno, L. A., & Nikolaev, V. G. (2012). Theoretical ground for adsorptive therapy of anthracyclines cardiotoxicity. Experimental Oncology, 34(4), 314–322.